ESPR   $2.51  0.80% Market Open

Esperion Therapeutics Inc
Total Cash 189.30M
totalCashPerShare 0.965
EBITDA 4.99M
Total Debt 269.14M
quickRatio 1.424
currentRatio 1.968
Total Revenue 277.79M
debtToEquity
Revenue/Share 1.907
ROA 0.01054
ROE
grossProfits
freeCashflow 6.91M
operatingCashflow -9.76M
earningsGrowth
revenueGrowth 1.863
grossMargins 0.6112
ebitdaMargins 0.01796
operatingMargins 0.034930002
profitMargins -0.35458001
enterpriseValue 495.83M
forwardPE 16.307692
floatShares 194.82M
sharesOutstanding 196.22M
sharesShort 35.39M
sharesShortPriorMonth 38.09M
dateShortInterest
sharesPercentSharesOut 0.18%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.69%
Short Ratio help_outline 10.64%
shortPercentOfFloat 0.18%
impliedSharesOutstanding
bookValue -1.769
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -98.50M
trailingEps -0.85%
forwardEps 0.13%
enterpriseToEbitda 99.36
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.18 3Q 2024
institutionsCount 212
lastUpdated Nov. 6, 2024, 5:23 p.m.